and up-to-date on our AI empowered digital cytology solutions.
.png)
- De-identified ThinPrep urine cytology slides (200) were retrospectively selected. Two cytopathologists (CP) provided consensus diagnoses (ground truth, GT) for all cases: 100 Negative for High-Grade Urothelial Carcinoma (NHGUC), 35 Atypical Urothelial Cells (AUC), 32 Suspicious for HGUC (SHGUC), and 33 HGUC.
- Slides were digitized into WSIs utilizing Mikroscan SLxCyto and customized Huron WSI imagers and examined using AI-assisted WSI review (AIxURO)
- 1 cytopathologist (CP) and 2 cytologists (CT) blindly reviewed slides with a 2-week washout period between research arms:
o Arm 1- Microscopy only
o Arm 2- AIxURO Mikroscan SLxCyto’s WSI review
o Arm 3- AIxURO customized Huron’s WSI review
- Performance Metrics:
o Comparison of study diagnosis with ground truth diagnosis for 3 Arms using following thresholds:
(1) AUC+ (AUC, SHGUC and HGUC) cases as positive; NHGUC cases as negative
(2) SHGUC+ (SHGUC and HGUC) cases as positive; NHGUC and AUC cases as negative
o The slide evaluation time (SET) in each arm was documented and made comparison.
- Diagnostic performance using the AUC+ threshold, AIxURO WSI review (Arm 2 and Arm 3) demonstrated higher sensitivity than microscopy (85.0% and 88.3% vs 79.3% overall). However, AIxURO WSI review exhibited lower specificity than microscopy (85.7% and 82.7% vs. 94.3%).
- When using the SHGUC+ threshold, AIxURO WSI review demonstrated higher overall sensitivity (74.9% and 86.2 vs 76.9%) and slightly lower specificity (96.0% and 92.3% vs 97.5% overall) compared to microscopy.
- AIxURO WSI review markedly reduced the SET versus microscopy (35.9s and 36.4s vs 102.6s). SETs for AUC+ are 45s and 43.6s vs 116.4s, while SET for negative cases are 26.5s and 29.1s vs 88.9s.
AIxURO WSI review demonstrated higher sensitivity but lower specificity than microscopy for AUC+ and SHGUC+ thresholds. Notably, AIxURO WSI review reduced slide evaluation time by at least 64.5%, offering substantial efficiency gains. These findings highlight AIxURO’s potential to enhance workflow efficiency in settings withstaffing shortages while maintaining diagnostic performance.
- 296 urine cytology slides from confirmed biopsy-positive cases within six months (70 AUC, 65 SHGUC,161 HGUC)
- Slides digitized into WSIs with Leica AT2 scanner
- AI algorithm identified and categorized cells with high (suspicious) or low (atypical) malignancy risk based on The Paris System for Reporting Urinary Cytology (TPS) features; Top-24 category order-ranks 24 most abnormal cells
- Performance Metrics: Mean values of suspicious cells, atypical cells, and the top-24 cells (cells ranked by highest probability of malignancy) with TPS features compared across the three categories (HGUC, SHGUC, and AUC).
- HGUC cases had significantly higher mean number of abnormal cells for top-24 cells (12.2 vs. 5.5 vs. 2.5), suspicious cells (91.6 vs. 13.1 vs. 2.7), and atypical cells (885.1 vs. 108.9 vs. 30.8) compared to SHGUC and AUC, respectively.
- Top-24 and suspicious cells displayed higher N:C ratio (0.65-0.66) and larger nuclear area (106-113 mm 2 ) than atypical cells (0.57 and 86-91 mm 2 ) across three categories.
- Percentage of cells with all 3 key TPS morphological features across 3 categories:
o Top-24 cells- 84%-95%
o Suspicious cells- 81%-91%
o Atypical cells- 22%-39%
- Critical distinguishing feature between suspicious and atypical was hyperchromasia
o 93% of suspicious cells
o 24%-40% of atypical cells.
- Percentage of top-24 / suspicious cells with all 3 TPS features:
o HGUC (95% / 91%)
o SHGUC (89% / 89%)
o AUC (84% / 81%)
HGUC showed the highest numbers of abnormal urothelial cells compared to SHGUC and AUC. N/C ratio and nuclear sizes were larger in top-24 and suspicious cell categories compared to the atypical cell category. Hyperchromasia was the most important distinguishing morphologic feature between suspicious and atypical cells. HGUC had the highest % of top-24 and suspicious cells with all 3 TPS morphologic features, indicating that the AI algorithm correctly selected features predicting HGUC. These findings highlight AI’s potential to enhance accuracy and efficiency in bladder cancer diagnosis.
- Ten de-identified ThinPrep Urocyte slides with surgical concordance as gold standard/ground truth (4 NHGUC, 2 AUC, 1 SHGUC, 3 HGUC) digitized into WSIs using five digital imagers:
o Leica Aperio AT2
o Hamamatsu S360
o 3DHistech P1000
o Customized Huron WSI model
o Mikroscan SLxCyto
- AI algorithm was applied to the WSIs to detect suspicious cells (high-malignant risk) and atypical urothelial cells (low-malignant risk).
- 3 cytologists (CT) reported diagnosis on slides with 2-week washout period between arms:
o Arm 1- Microscopy only
o Arm 2- AI-assisted WSI review
- Performance Metrics:
o WSI conversion rate
o Comparison of binary (positive vs negative) diagnosis (AUC, SHGUC, and HGUC cases = positive) with ground truth diagnosis for 2 Arms
o Quantitative data analysis
- All digital imagers achieved a 100% WSI conversion rate.
- In the binary diagnosis, AI-assisted WSI review demonstrated performance comparable to microscopy across all imagers
- Quantitative analysis revealed slight variations in key metrics, including suspicious/atypical cell numbers, nuclear-to-cytoplasmic (N:C) ratio, and nuclear area, among WSIs produced by different imagers
First study to assess multiple digital pathology imagers for AI-assisted urine cytology. Results demonstrate that a disease-specific AI algorithm produces consistent diagnostic performance and quantitative analysis across different WSIs, supporting its potential to enhance diagnostic accuracy across imaging platforms.
- 116 urine (76 cytospin; 40 CytoRich) cytology slides with 3-armed microscopy, corresponding WSI and AI-digital (AIxURO) review by 1 experienced cytopathologist and 2 cytologists
- Performance metrics calculated for each arm included binary (negative vs positive) diagnosis, inter-and intra-observer agreement, and screening time
- Atypical Urothelial Cells (AUC): AIxURO improved diagnostic sensitivity (from 25-30.6% to 63.9%), PPV (from 21.6-24.3% to 31.1%), and NPV (91.3-19.6%) to 95.3%)
- Suspicious for High-Grade Urothelial Carcinoma (SHGUC): AIxURO improved sensitivity (from 15.2-27.3% to 33.3%), PPV (from 31.3-47.4% to 61.1%), and NPV (from 91.6%-92.7% to 93.3%).
- Binary Diagnosis (Negative vs Positive [AUC, SHGUC, or HGUC]): AIxURO improved sensitivity (from 77.8-82.2% to 90.0%) and NPV (from 91.7-93.4% to 95.8%)
- Interobserver agreement: Moderate concurrence across all methods of evaluation (ĸ = 0.57-0.61); cytopathologist showed the highest intraobserver agreement (ĸ = 0.75-0.88)
- Screening time: AIxURO significantly reduced screening time compared to conventional microscopy for all observers (by 52.3% to 83.2%); AUC case
The most significant finding is the marked reduction in screening time for AI-enhancement (AIxURO) compared with conventional microscopy (up to 83% less time required). Implementation of AI enhancement (AIxURO) for urine cytology interpretation improves diagnostic sensitivity, PPV and NPV for AUC and SHGUC, but not HGUC.
AIxURO improves the sensitivity and NPV of a binary interpretation of negative or positive. The interobserver agreement across all methods of review (microscopy, WSI and AIxURO) is moderate (ĸ = 0.57-0.61) with the cytopathologist showing the highest intra-observer agreement.
- 200 urine cytology slides (100 positive, 100 negative) were scanned to create whole slide images (WSI) that were analyzed by an artificial intelligence (AI)-assisted software program (AIxURO) to detect and quantify characteristics of abnormal urothelial cells
- Three study arms, each performed by 3 reviewers (1 cytopathologist, 2 cytologists) rendering the Paris System (TPS) 2.0 interpretation (2-week washout period between each arm):
- ARM 1- Glass slide microscopic interpretation
- ARM 2- Whole slide image interpretation
- ARM 3- WSI with AI-assisted interpretation (AIxURO)
- Performance Metrics: Total screening/reporting time, sensitivity and specificity compared to the ground truth diagnosis
- Average screening and reporting time was significantly reduced by 25.8%-58.7% (p < 0.05)
- Microscopy only and AI-assisted (AIxURO) outperformed WSI-only review in both sensitivity and specificity
- AIxURO was slightly less sensitive than microscopy (66.0 - 87.0% vs. 86.0 -89.0%) but more specific (89.0 – 95.0% vs. 81.0 – 88.0%).
- Use of AIxURO reclassified some ground-truth diagnoses from HGUC or SHGUC to AUC or NHGUC.
The use of an AI-assisted software platform (AIxURO) for detection of bladder carcinoma improves overall specificity in comparison with microscopic glass slide or whole slide imaging review, while significantly reducing screening and reporting time.
- 1856 urine cytology cases (1466 negative and 390 positive)- AI training set
- 169 urine cytology cases (88 negative, 81 positive)- Validation set
- AIxURO classifies abnormal urothelial cells into 2 categories based on The Paris System 2.0: “Suspicious” (SHGUC or HGUC) and “Atypical “(AUC), with the final interpretation deferred to a pathologist
- Logistic regression performed to predict presence of cancer, including variables such as total # suspicious cells, total # atypical cells, and predictive accuracy using sensitivity and specificity
- Optimal performance of the training set (based on the total number of atypical cells) was 10 cells (cytospin) and 49 cells (CytoRich)
- Training Set Sensitivity and Specificity: 75.9% and 73.0%
- Validation Set Sensitivity and Specificity: 75.3% and 87.5%
The logistic model supports the optimal cut-off values of at least 10 cells (cytospin) and 49 cells (CytoRich) for the number of atypical cells required for a high concordance with bladder cancer as the final outcome.
- 52 urine cytology slides (cytospin, ThinPrep, and CytoRIch) scanned with 21 Z-plane and a heuristic scan simulation method to generate whole slide images (WSI) using a Leica Aperio AT2 scanner
- An AI algorithm inferred the WSI from 21 Z-planes to quantitate total number of cells suspicious for high grade urothelial carcinoma (SHGUC) / high-grade urothelial carcinoma (HGUC)=[SHGUC+]
- The heuristic scan simulation calculated the total number of SHGUC+ using the 21 Z-plane scan data
- Performance metrics evaluated were SHGUC+ cell coverage rates, scanning times, file size, and AI-aided interpretation of WSI compared to the original cytology diagnosis for the 21 Z-plane scan and the heuristic scan
- SHGUC+ Coverage Rates: Heuristic scanning coverage rates were similar to 5 Z-plane scans for all 3 preparation types (0.78 to 0.91 vs 0.75 to 0.88; p = 0.451 to 0.578)
- Scanning Time: Heuristic scanning significantly reduced scanning time (137.2 to 635.0 seconds vs 332.6 to 1,278.8 seconds; p < 0.05)
- Image File Size: Heuristic scanning significantly reduced image file size (0.51 to 2.10 GB vs. 1.16 to 3.10 GB; p < 0.05)
- AI-aided Interpretation: Heuristic scanning had higher rates of accurate interpretation compared to single Z-plan scanning (62.5% vs. 37.5%)
Heuristic scanning showed improved scanning times and AI-aided cytologic interpretation while reducing overall image file size and maintaining similar scanning coverage for SHGUC+ cells for 3 urine cytology preparation types.
- 116 urine cytology slides (76 Cytospin, 40 CytoRich)
- Consensus diagnosis by two senior cytopathologists for ground truth, using TPS2.0, resulting in
- 30 positive slides (AUC/SHGUC/HGUC)
- 86 negative slides (NHGUC)
- Consensus diagnosis by two senior cytopathologists for ground truth, using TPS2.0, resulting in
- 3-Arm study with 1 cytopathologist (CP) and 2 cytologist (CT) reviewers and a 2-week washout period between each arm; and analysis of the cytopathologist paired with one of the cytologists to mimic clinical practice of cytologist review and referral to cytopathologist
- Arm 1: Microscopy
- Arm 2: Digital whole slide image review
- Arm 3: Digital image review using artificial intelligence software (AIxURO)
- Performances Metrics: Sensitivity, specificity, PPV, NPV, accuracy and total diagnostic (review) time
- Sensitivity: Improved with AI-assistance for CP+CTA (90% vs 76.7%) and CP+CTB (76.7% vs 76.7%) compared with microscopy (but not with WSI review alone)
- Negative Predictive Value: Improved with AI-assistance for CP+CTA (96.4% vs 92.2%) and CP+CTB (92% vs 92.3%) compared with microscopy (but not with WSI review alone)
- Specificity: Decreased in AI-assistance for CP+CTA (93% vs 96.5%) and CP+CTB (92% vs 92.3%) compared to microscopy alone
- Positive Predictive Value: Decreased in AI-assistance for CP+CTA (81.8% vs 88.5%) and CP+CTB (79.3% vs 92%) compared to microscopy alone
- Overall, Arm 2 (WSI review) showed no improvement compared to microscopy for either CP+CTA or CP+CTB
- Overall Review Time: AI-assisted review decreased the total review time (72.2 min and 110.4 min), compared to microscopy (210.2 min and 244.7 min), whereas WSI review took as long or longer (227.1 min and 243.8 min) than microscopy
AI-assisted urine cytology review markedly reduces review time while increasing sensitivity and NPV using TPS2.0 compared to conventional microscopy. However, specificity, PPV and accuracy are slightly diminished. Pairing a cytopathologist (CP) with different cytologists (CT) also influences the diagnostic outcomes and metrics.
- 116 urine cytology slides with consensus diagnosis (ground truth) by a panel of experts to 86 NHGUC, 12 AUC, 11 SHGUC, and 7 HGUC, scanned with Leica Aperio AT2 to create a whole slide image (WSI)
- 1 Cytopathologist and 2 cytologists reviewed all slides/images in each arm independently, recording the time required to diagnosis and The Paris System (TPS) cytologic diagnosis, with a 2-week washout period between each review
- Arm 1: Microscopic review of the cytology slide
- Arm 2: Review of the scanned whole slide image (WSI)
- Arm 3: Review of images with AI-assistance software (AIxURO)
- Metrics: TPS diagnostic category compared with the expert panel and Total time spent on review
- NHGUC, SHGUC and HGUC: AIxURO showed higher specificity than microscopy, but lower sensitivity
- AUC: AIxURO showed higher sensitivity but lower specificity than microscopy
- The performance of Arm 2 (using the whole slide digital image only for analysis) was poorest overall, compared to the other 2 arms
- There were performance inconsistencies between reviewers. For example, sensitivity for SHGUC was decreased for the pathologist and one cytologist, whereas the other cytologist noted an increase in sensitivity. One cytologist had a decrease in sensitivity for HGUC compared to the other 2 reviewers.
- AIxURO showed the largest reduction in time spent on review (32-45% less for the pathologist and 10-62% for the cytologists). The cytopathologist took the longest time to review AUC and the shortest for HGUC, whereas the cytologists took the most time to review SHGUC and the least on NHGUC.
AI-assisted AIxURO outperformed microscopy in diagnostic accuracy for AUC while maintaining comparable accuracy across other TPS categories and significantly reducing total review time for all reviewers. WSI review alone did not improve diagnostic accuracy or efficiency.